Hope and Progress: New Evidence That Millions More Cancer Patients May Now Benefit from Revolutionary Immunotherapy Drugs

Updated May 28th, 2019

Hope and Progress: New Evidence That Millions More Cancer Patients May Now Benefit from Revolutionary Immunotherapy Drugs

The percentage of cancer patients eligible for so-called "checkpoint inhibitors" has soared more than 40 percent since 2011

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.